Schizophenia Libility Genes among African-Americans
非裔美国人的精神分裂症易感基因
基本信息
- 批准号:6647738
- 负责人:
- 金额:$ 49.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-01 至 2007-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): It is now obvious that large samples are essential to make much headway on the genetics of schizophrenia (SCZ). To identify genes that underlie liability to SCZ, we will recruit a large and diverse sample of 1260 African- American families, primarily from the southeastern US, all of whom have at least one member diagnosed with SCZ. A substantial portion of this diverse set of families will contribute to standard Affected Sibling and Relative Pair linkage analysis and to Quantitative Trait Locus (QTL) analyses of neurocognitive traits; the entire sample will be used for admixture mapping in candidate regions of interest This project also lays the foundation for QTL analysis by examining genetic influences on cognitive abilities among persons affected by SCZ and their extended family members. This minority sample would be impossible to recruit without multiple participating sites using the same protocol. Eight institutional sites have teamed up under the Collaborative ROls for Clinical Studies of Mental Disorders to accomplish this goal. The collaboration marries expertise in diagnoses, neurocognitive assessments, family recruitment, and genetic analyses. Substantial samples and refined, multivariate phenotypes should combine to give unprecedented power to determine susceptibility genes for this disease.
Our study design is motivated by several considerations. The time is ripe for merging finer phenotypic information with rigorous diagnosis, and the analytic tools are in place, both for finer phenotypic characterization and the joint analysis of phenotypes and genotypes. In terms of mental health, African Americans are an underserved population. The genetic basis of SCZ in the African-American population must have its roots in both Africa and Europe. if the liability alleles for SCZ were different on the two continents, either in kind or frequency, then what we learn from the study of peoples of European ancestry will not necessarily transfer seamlessly to the African population and, by extension, to the African-American population. Therefore it is essential to study SCZ genetics in African-American populations. Finally, we have an outstanding track record of African American participation in research studies, and a deep appreciation of their population genetics.
描述(由申请人提供):现在很明显,要在精神分裂症(SCZ)的遗传学上取得很大进展,大样本是必不可少的。为了确定导致SCZ的基因,我们将招募1260个非洲裔美国家庭的大量不同样本,主要来自美国东南部,所有家庭至少有一名成员被诊断患有SCZ。这一多样化的家族的很大一部分将有助于标准的影响兄弟姐妹和亲属对连锁分析和神经认知特征的数量性状位点(QTL)分析;整个样本将用于候选感兴趣区域的混合定位。该项目还为QTL分析奠定了基础,通过检查SCZ患者及其大家庭成员对认知能力的遗传影响。如果没有使用相同协议的多个参与站点,就不可能招募到这些少数样本。为了实现这一目标,八家机构已经在精神疾病临床研究合作项目下联合起来。这项合作结合了诊断、神经认知评估、家庭招募和基因分析方面的专业知识。大量的样本和精细的多变量表型相结合,将为确定这种疾病的易感基因提供前所未有的力量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph Patrick McEvoy其他文献
Diazepam for catatonia.
地西泮治疗紧张症。
- DOI:
10.1176/ajp.141.2.284 - 发表时间:
1984 - 期刊:
- 影响因子:0
- 作者:
Joseph Patrick McEvoy;Lohr Jb - 通讯作者:
Lohr Jb
Organic brain syndromes.
器质性脑综合症。
- DOI:
- 发表时间:
1981 - 期刊:
- 影响因子:39.2
- 作者:
Joseph Patrick McEvoy - 通讯作者:
Joseph Patrick McEvoy
Joseph Patrick McEvoy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph Patrick McEvoy', 18)}}的其他基金
7/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
7/7 氯氮平预防精神分裂症暴力:一项随机临床试验
- 批准号:
10442520 - 财政年份:2021
- 资助金额:
$ 49.73万 - 项目类别:
7/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
7/7 氯氮平预防精神分裂症暴力:一项随机临床试验
- 批准号:
10193994 - 财政年份:2021
- 资助金额:
$ 49.73万 - 项目类别:
7/7 Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial
7/7 氯氮平预防精神分裂症暴力:一项随机临床试验
- 批准号:
10655396 - 财政年份:2021
- 资助金额:
$ 49.73万 - 项目类别:
1/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
1/2-A 精神分裂症长效注射药物的比较 -ACLAIMS
- 批准号:
8323934 - 财政年份:2009
- 资助金额:
$ 49.73万 - 项目类别:
1/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
1/2-A 精神分裂症长效注射药物的比较 -ACLAIMS
- 批准号:
7882532 - 财政年份:2009
- 资助金额:
$ 49.73万 - 项目类别:
1/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
1/2-A 精神分裂症长效注射药物的比较 -ACLAIMS
- 批准号:
8073566 - 财政年份:2009
- 资助金额:
$ 49.73万 - 项目类别:
1/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
1/2-A 精神分裂症长效注射药物的比较 -ACLAIMS
- 批准号:
7582905 - 财政年份:2009
- 资助金额:
$ 49.73万 - 项目类别:
Schizophenia Libility Genes among African-Americans
非裔美国人的精神分裂症易感基因
- 批准号:
6905606 - 财政年份:2002
- 资助金额:
$ 49.73万 - 项目类别:
Schizophenia Libility Genes among African-Americans
非裔美国人的精神分裂症易感基因
- 批准号:
7117379 - 财政年份:2002
- 资助金额:
$ 49.73万 - 项目类别:
Schizophenia Libility Genes among African-Americans
非裔美国人的精神分裂症易感基因
- 批准号:
6785857 - 财政年份:2002
- 资助金额:
$ 49.73万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 49.73万 - 项目类别:
Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 49.73万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 49.73万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 49.73万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 49.73万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 49.73万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 49.73万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 49.73万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 49.73万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 49.73万 - 项目类别: